Literature DB >> 27671918

Anxiety Disorders and Cardiovascular Disease.

Christopher M Celano1,2, Daniel J Daunis3,4, Hermioni N Lokko3,5, Kirsti A Campbell3,4, Jeff C Huffman3,4.   

Abstract

Anxiety and its associated disorders are common in patients with cardiovascular disease and may significantly influence cardiac health. Anxiety disorders are associated with the onset and progression of cardiac disease, and in many instances have been linked to adverse cardiovascular outcomes, including mortality. Both physiologic (autonomic dysfunction, inflammation, endothelial dysfunction, changes in platelet aggregation) and health behavior mechanisms may help to explain the relationships between anxiety disorders and cardiovascular disease. Given the associations between anxiety disorders and poor cardiac health, the timely and accurate identification and treatment of these conditions is of the utmost importance. Fortunately, pharmacologic and psychotherapeutic interventions for the management of anxiety disorders are generally safe and effective. Further study is needed to determine whether interventions to treat anxiety disorders ultimately impact both psychiatric and cardiovascular health.

Entities:  

Keywords:  Anxiety; Cardiovascular disease; Generalized anxiety disorder; Panic disorder; Post-traumatic stress disorder

Mesh:

Substances:

Year:  2016        PMID: 27671918      PMCID: PMC5149447          DOI: 10.1007/s11920-016-0739-5

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  125 in total

Review 1.  31st Bethesda Conference. Emergency Cardiac Care. Task force 2: Acute coronary syndromes: Section 2B--Chest discomfort evaluation in the hospital.

Authors:  A M Hutter; E A Amsterdam; A S Jaffe
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

2.  Myocardial infarction and generalised anxiety disorder: 10-year follow-up.

Authors:  Annelieke M Roest; Marij Zuidersma; Peter de Jonge
Journal:  Br J Psychiatry       Date:  2012-03-08       Impact factor: 9.319

3.  Anxiety and risk of incident coronary heart disease: a meta-analysis.

Authors:  Annelieke M Roest; Elisabeth J Martens; Peter de Jonge; Johan Denollet
Journal:  J Am Coll Cardiol       Date:  2010-06-29       Impact factor: 24.094

4.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Authors:  François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

5.  Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies.

Authors:  Marlies R de Jong; Maarten Van der Elst; Klaas A Hartholt
Journal:  Ther Adv Drug Saf       Date:  2013-08

6.  Predictors of attendance at cardiac rehabilitation after myocardial infarction.

Authors:  D Lane; D Carroll; C Ring; D G Beevers; G Y Lip
Journal:  J Psychosom Res       Date:  2001-09       Impact factor: 3.006

7.  A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.

Authors:  Stephen S Gottlieb; Willem J Kop; Sue A Thomas; Scott Katzen; Mark R Vesely; Nancy Greenberg; Joanne Marshall; Michelle Cines; Stacey Minshall
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

8.  Relation of anxiety and adherence to risk-reducing recommendations following myocardial infarction.

Authors:  Emily A Kuhl; James A Fauerbach; David E Bush; Roy C Ziegelstein
Journal:  Am J Cardiol       Date:  2009-04-16       Impact factor: 2.778

9.  Early life adversity and/or posttraumatic stress disorder severity are associated with poor diet quality, including consumption of trans fatty acids, and fewer hours of resting or sleeping in a US middle-aged population: A cross-sectional and prospective study.

Authors:  Anna Gavrieli; Olivia M Farr; Cynthia R Davis; Judith A Crowell; Christos S Mantzoros
Journal:  Metabolism       Date:  2015-09-26       Impact factor: 8.694

10.  A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.

Authors:  Renerio Fraguas; Renata Martinho da Silva Telles; Tânia Correa Toledo Ferraz Alves; Anna Maria Andrei; Jairo Rays; Dan V Iosifescu; Mauricio Wajngarten
Journal:  Contemp Clin Trials       Date:  2009-01-24       Impact factor: 2.226

View more
  43 in total

1.  The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain.

Authors:  Constanza Daigre; Lara Grau-López; Laia Rodríguez-Cintas; Elena Ros-Cucurull; Marta Sorribes-Puertas; Oriol Esculies; Katia Bones-Rocha; Carlos Roncero
Journal:  Qual Life Res       Date:  2017-08-07       Impact factor: 4.147

Review 2.  Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension.

Authors:  Jasenka Zubcevic; Elaine M Richards; Tao Yang; Seungbum Kim; Colin Sumners; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 3.  Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.

Authors:  Napatsorn Saiyasit; Evan-Angelo R Butlig; Samantha D Chaney; Miranda K Traylor; Nanako A Hawley; Ryleigh B Randall; Hanna V Bobinger; Carl A Frizell; Franklin Trimm; Errol D Crook; Mike Lin; Benjamin D Hill; Joshua L Keller; Amy R Nelson
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

4.  The association between cardiac drug therapy and anxiety among cardiac patients: results from the national DenHeart survey.

Authors:  Camilla Rotvig; Anne Vinggaard Christensen; Knud Juel; Jesper Hastrup Svendsen; Martin Balslev Jørgensen; Trine Bernholdt Rasmussen; Britt Borregaard; Lars Thrysoee; Charlotte Brun Thorup; Rikke Elmose Mols; Selina Kikkenborg Berg
Journal:  BMC Cardiovasc Disord       Date:  2022-06-20       Impact factor: 2.174

Review 5.  Autonomic Neural Circuit and Intervention for Comorbidity Anxiety and Cardiovascular Disease.

Authors:  Xuanzhao Chen; Li Xu; Zeyan Li
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

6.  Stress management interventions for adults with heart failure: Systematic review and meta-analysis.

Authors:  Emily C Gathright; Elena Salmoirago-Blotcher; Julie DeCosta; Marissa L Donahue; Melissa M Feulner; Dean G Cruess; Rena R Wing; Michael P Carey; Lori A J Scott-Sheldon
Journal:  Health Psychol       Date:  2021-09       Impact factor: 5.556

7.  Prevelance of depression and anxiety with their effect on quality of life in chronic kidney disease patients.

Authors:  Sameeha Alshelleh; Abdullah Alhouri; Alaa Taifour; Bilal Abu-Hussein; Faris Alwreikat; Mohammad Abdelghani; Muhannad Badran; Yousef Al-Asa'd; Hussein Alhawari; Ashraf O Oweis
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

8.  Single-Session Acceptance and Commitment Therapy (ACT) Interventions for Patients with Chronic Health Conditions: A Systematic Review and Meta-Analysis.

Authors:  Cara Dochat; Jennalee S Wooldridge; Matthew S Herbert; Michael W Lee; Niloofar Afari
Journal:  J Contextual Behav Sci       Date:  2021-03-06

9.  The intersection of depression, anxiety, and cardiovascular disease among black populations amid the COVID-19 pandemic.

Authors:  Nia Josiah; Shaquita Starks; Patty R Wilson; Tamar Rodney; Joyell Arscott; Yvonne Commodore-Mensah; Ruth-Alma Turkson-Ocran; Kynadi Mauney; Oluwabunmi Ogungbe; Janelle Akomah; Diana-Lyn Baptiste
Journal:  J Clin Nurs       Date:  2021-01-18       Impact factor: 4.423

10.  Effects of Acute Exercise on Anxiety Ratings in Patients With Coronary Heart Disease and Elevated Anxiety.

Authors:  Hannah M Malian; Patrick J Smith; Benson Hoffman; Wei Jiang; Katharine Ammerman; William E Kraus; Alan Hinderliter; Andrew Sherwood; James A Blumenthal
Journal:  J Cardiopulm Rehabil Prev       Date:  2021-07-01       Impact factor: 3.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.